References
- Rigau V, Association des Neuro-Oncologues d’Expression Française (ANOCEF), S, Zouaoui H, Mathieu-Daude, et al. French brain tumor database: 5-year histological results on 25 756 cases. Brain Pathol. 2011; 21(6):633–644.
- Choi SM, O'Malley DP. Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms. Ann Diagn Pathol. 2018; 37(2):67–74.
- Citterio G, Calimeri T, Ferreri AJM. Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphoma. Expert Rev Neurother. 2018;18(5):1–15.
- Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma. Surv Ophthalmol. 2014;59(5):503–516.
- Gerstner ER, Batchelor TT. Primary central nervous system lymphoma. Arch Neurol. 2010;67(3):291–297.
- Fox CP, British Society for Haematology, EH, Phillips J, Smith, et al. Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma. Br J Haematol. 2019;184(3):348–363.
- Panageas KS, Elkin EB, DeAngelis LM, et al. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis. Cancer. 2005;104(11):2466–2472.
- Chamberlain MC. High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma. Neurology. 2015;84(7):758–759.
- Zhou M, Xu G. Recent progress in the diagnosis and treatment of primary vitreoretinal lymphoma. Taiwan J Ophthalmol. 2016;6(4):170–176.
- Wang Y, Shen D, Wang VM, et al. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma. Int J Mol Sci. 2011;12(9):5684–5697.
- Kimura K, Japanese Intraocular Lymphoma Study Group, Usui H. Goto Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012;56(4):383–389.
- Pochat-Cotilloux C, Bienvenu J, Nguyen AM, et al. Use of a Threshold of Interleukin-10 and Il-10/Il-6 ratio in ocular samples for the screening of vitreoretinal lymphoma. Retina. 2018;38(4):773–781.
- Wang L, Luo L, Gao Z, et al. The diagnostic and prognostic value of interleukin-10 in cerebrospinal fluid for central nervous system lymphoma: a meta-analysis. Leuk Lymphoma. 2017;58(10):2452–2459.
- Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist. 2011;16(11):1589–1599.
- Kuker W, Herrlinger U, Gronewaller E, et al. Ocular manifestation of primary nervous system lymphoma: what can be expected from imaging? J Neurol. 2002;249(12):1713–1716.
- Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol. 2011;32(6):984–992.
- Zacharia TT, Law M, Naidich TP, et al. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy. J Neuroimaging. 2008;18(4):411–417.
- Calli C, Kitis O, Yunten N, et al. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol. 2006;58(3):394–403.
- Manoj N, Arivazhagan A, Mahadevan A, et al. Central nervous system lymphoma: patterns of incidence in Indian population and effect of steroids on stereotactic biopsy yield. Neurol India. 2014;62(1):19–25.
- De Graaff HJ, Wattjes MP, Rozemuller-Kwakkel AJ, et al. Fatal B-cell lymphoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. JAMA Neurol. 2013;70(7):915–918.
- Javier R, Shaikh N, Lesniak MS, et al. B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma. Diagn Pathol. 2018;13(1):37.
- Alderson L, Fetell MR, Sisti M, et al. Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry. 1996;60(1):102–105.